DE3544373A1 - Process for the preparation of phosphinothricin-carboxamides - Google Patents
Process for the preparation of phosphinothricin-carboxamidesInfo
- Publication number
- DE3544373A1 DE3544373A1 DE19853544373 DE3544373A DE3544373A1 DE 3544373 A1 DE3544373 A1 DE 3544373A1 DE 19853544373 DE19853544373 DE 19853544373 DE 3544373 A DE3544373 A DE 3544373A DE 3544373 A1 DE3544373 A1 DE 3544373A1
- Authority
- DE
- Germany
- Prior art keywords
- alkyl
- formula
- carboxamides
- amino
- condensing agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000000034 method Methods 0.000 title claims abstract description 8
- 238000002360 preparation method Methods 0.000 title claims abstract description 5
- 150000001412 amines Chemical class 0.000 claims abstract description 9
- 125000006239 protecting group Chemical group 0.000 claims abstract description 9
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 claims description 15
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 claims description 9
- 239000003795 chemical substances by application Substances 0.000 claims description 7
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 6
- 150000001718 carbodiimides Chemical class 0.000 claims description 6
- 229910052739 hydrogen Inorganic materials 0.000 claims description 6
- 239000001257 hydrogen Substances 0.000 claims description 6
- 125000003282 alkyl amino group Chemical group 0.000 claims description 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 4
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 4
- 125000003118 aryl group Chemical group 0.000 claims description 3
- 150000001244 carboxylic acid anhydrides Chemical class 0.000 claims description 3
- 125000001072 heteroaryl group Chemical group 0.000 claims description 3
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 125000004400 (C1-C12) alkyl group Chemical group 0.000 claims description 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims description 2
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 claims description 2
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims description 2
- 125000003342 alkenyl group Chemical group 0.000 claims description 2
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 2
- 125000004414 alkyl thio group Chemical group 0.000 claims description 2
- 125000002947 alkylene group Chemical group 0.000 claims description 2
- 125000000304 alkynyl group Chemical group 0.000 claims description 2
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 claims description 2
- 125000001769 aryl amino group Chemical group 0.000 claims description 2
- 125000004104 aryloxy group Chemical group 0.000 claims description 2
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims description 2
- 150000003857 carboxamides Chemical class 0.000 claims description 2
- 125000005843 halogen group Chemical group 0.000 claims description 2
- 125000005842 heteroatom Chemical group 0.000 claims description 2
- 229910052760 oxygen Inorganic materials 0.000 claims description 2
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 2
- 125000004434 sulfur atom Chemical group 0.000 claims description 2
- IAJOBQBIJHVGMQ-BYPYZUCNSA-M glufosinate-P zwitterion(1-) Chemical class CP([O-])(=O)CC[C@H](N)C(O)=O IAJOBQBIJHVGMQ-BYPYZUCNSA-M 0.000 claims 1
- 150000008064 anhydrides Chemical class 0.000 abstract description 4
- IAJOBQBIJHVGMQ-BYPYZUCNSA-N glufosinate-P Chemical compound CP(O)(=O)CC[C@H](N)C(O)=O IAJOBQBIJHVGMQ-BYPYZUCNSA-N 0.000 abstract description 4
- IAJOBQBIJHVGMQ-UHFFFAOYSA-N Phosphinothricin Natural products CP(O)(=O)CCC(N)C(O)=O IAJOBQBIJHVGMQ-UHFFFAOYSA-N 0.000 abstract description 3
- 230000008030 elimination Effects 0.000 abstract 1
- 238000003379 elimination reaction Methods 0.000 abstract 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 24
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 14
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 13
- -1 naphthyl radicals Chemical class 0.000 description 11
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 10
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 8
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 8
- 239000002904 solvent Substances 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 239000003054 catalyst Substances 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 229960000583 acetic acid Drugs 0.000 description 5
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 5
- 239000012362 glacial acetic acid Substances 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 5
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 229910052763 palladium Inorganic materials 0.000 description 4
- 229910052938 sodium sulfate Inorganic materials 0.000 description 4
- 235000011152 sodium sulphate Nutrition 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- ADFXKUOMJKEIND-UHFFFAOYSA-N 1,3-dicyclohexylurea Chemical compound C1CCCCC1NC(=O)NC1CCCCC1 ADFXKUOMJKEIND-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
- 239000008346 aqueous phase Substances 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 125000000612 phthaloyl group Chemical group C(C=1C(C(=O)*)=CC=CC1)(=O)* 0.000 description 3
- GWEHVDNNLFDJLR-UHFFFAOYSA-N 1,3-diphenylurea Chemical compound C=1C=CC=CC=1NC(=O)NC1=CC=CC=C1 GWEHVDNNLFDJLR-UHFFFAOYSA-N 0.000 description 2
- HVCNXQOWACZAFN-UHFFFAOYSA-N 4-ethylmorpholine Chemical compound CCN1CCOCC1 HVCNXQOWACZAFN-UHFFFAOYSA-N 0.000 description 2
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- AFBPFSWMIHJQDM-UHFFFAOYSA-N N-methylaniline Chemical compound CNC1=CC=CC=C1 AFBPFSWMIHJQDM-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- XKDUZXVNQOZCFC-UHFFFAOYSA-N hexan-1-amine;hydron;chloride Chemical compound Cl.CCCCCCN XKDUZXVNQOZCFC-UHFFFAOYSA-N 0.000 description 2
- 150000007530 organic bases Chemical group 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- ACVYVLVWPXVTIT-UHFFFAOYSA-N phosphinic acid Chemical group O[PH2]=O ACVYVLVWPXVTIT-UHFFFAOYSA-N 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 2
- 125000004044 trifluoroacetyl group Chemical group FC(C(=O)*)(F)F 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical group CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 description 1
- WGCYRFWNGRMRJA-UHFFFAOYSA-N 1-ethylpiperazine Chemical compound CCN1CCNCC1 WGCYRFWNGRMRJA-UHFFFAOYSA-N 0.000 description 1
- BMVXCPBXGZKUPN-UHFFFAOYSA-N 1-hexanamine Chemical compound CCCCCCN BMVXCPBXGZKUPN-UHFFFAOYSA-N 0.000 description 1
- WSNDAYQNZRJGMJ-UHFFFAOYSA-N 2,2,2-trifluoroethanone Chemical compound FC(F)(F)[C]=O WSNDAYQNZRJGMJ-UHFFFAOYSA-N 0.000 description 1
- MDKHWJFKHDRFFZ-UHFFFAOYSA-N 3,5-dimethylmorpholine Chemical compound CC1COCC(C)N1 MDKHWJFKHDRFFZ-UHFFFAOYSA-N 0.000 description 1
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 description 1
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000007933 aliphatic carboxylic acids Chemical class 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- MMCPOSDMTGQNKG-UHFFFAOYSA-N anilinium chloride Chemical compound Cl.NC1=CC=CC=C1 MMCPOSDMTGQNKG-UHFFFAOYSA-N 0.000 description 1
- ZSIQJIWKELUFRJ-UHFFFAOYSA-N azepane Chemical compound C1CCCNCC1 ZSIQJIWKELUFRJ-UHFFFAOYSA-N 0.000 description 1
- QXNDZONIWRINJR-UHFFFAOYSA-N azocane Chemical group C1CCCNCCC1 QXNDZONIWRINJR-UHFFFAOYSA-N 0.000 description 1
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- ALBYIUDWACNRRB-UHFFFAOYSA-N hexanamide Chemical compound CCCCCC(N)=O ALBYIUDWACNRRB-UHFFFAOYSA-N 0.000 description 1
- 238000006698 hydrazinolysis reaction Methods 0.000 description 1
- 238000007327 hydrogenolysis reaction Methods 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 125000005956 isoquinolyl group Chemical group 0.000 description 1
- 125000001786 isothiazolyl group Chemical group 0.000 description 1
- 125000000842 isoxazolyl group Chemical group 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 238000005580 one pot reaction Methods 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 125000002755 pyrazolinyl group Chemical group 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 description 1
- 125000005493 quinolyl group Chemical group 0.000 description 1
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 125000002769 thiazolinyl group Chemical group 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
- C07F9/301—Acyclic saturated acids which can have further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/58—Pyridine rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Gegenstand der vorliegenden Erfindung ist ein Verfahren zur
Herstellung von Carboxamiden der allgemeinen Formel
worin
R1 und R2 unabhängig voneinander Wasserstoff, (C1-C12)-
Alkyl, (C3-C8)-Alkenyl, (C3-C8)-Alkinyl, (C3-C8)-Cycloalkyl,
Aryl, Heteroaryl mit 1 oder 2 N-, O- oder S-
Atomen, Aryl-(C1-C2)-alkyl, Arylamino, wobei die genannten
Gruppen ihrerseits durch ein oder mehrere
Halogenatome, NH2, NH-(C1-C4)-Alkyl, OH, SH, NO2, CF3,
(C1-C4)-Alkoxy, Aryloxy, (C1-C4)-Alkylthio, (C1-C4)-
Alkoxycarbonyl, COOH, CONH2, CN, ((C1-C4)Alkylamino), Di-(C1-C4)-alkylamino
-oder Sulfamoyl substituiert sein können, oder
R1 und R2 gemeinsam eine gegebenenfalls substituierte
(C2-C7)-Alkylenkette, die durch ein oder mehrere
Heteroatome unterbrochen sein kann,
bedeuten, sowie von deren Salzen, das dadurch gekennzeichnet
ist, daß man Phosphinothricinderivate der Formel
worin
A eine übliche Aminoschutzgruppe bedeutet, mit einem Kondensationsmittel
aus der Reihe der Carbodiimide oder
Carbonsäureanhydride und einem Amin der Formel
umsetzt und die Schutzgruppen anschließend abspaltet.The present invention relates to a process for the preparation of carboxamides of the general formula wherein
R 1 and R 2 independently of one another are hydrogen, (C 1 -C 12 ) alkyl, (C 3 -C 8 ) alkenyl, (C 3 -C 8 ) alkynyl, (C 3 -C 8 ) cycloalkyl, aryl , Heteroaryl with 1 or 2 N, O or S atoms, aryl (C 1 -C 2 ) alkyl, arylamino, where the groups mentioned in turn are formed by one or more halogen atoms, NH 2 , NH- (C 1 - C 4 ) alkyl, OH, SH, NO 2 , CF 3 , (C 1 -C 4 ) alkoxy, aryloxy, (C 1 -C 4 ) alkylthio, (C 1 -C 4 ) alkoxycarbonyl, COOH, CONH 2 , CN, ((C 1 -C 4 ) alkylamino), di (C 1 -C 4 ) alkylamino or sulfamoyl may be substituted, or
R 1 and R 2 together form an optionally substituted (C 2 -C 7 ) alkylene chain which can be interrupted by one or more heteroatoms,
mean, and of their salts, which is characterized in that phosphinothricine derivatives of the formula wherein
A represents a common amino protecting group, with a condensing agent from the series of carbodiimides or carboxylic anhydrides and an amine of the formula implemented and the protective groups then split off.
Die Verbindungen der Formel I sind teilweise aus der DE-OS 27 17 440 als Totalherbizide bekannt. An gleicher Stelle wird eine Methode zur Darstellung des Phosphinothricincarbanilids gegeben, die aber nur eine sehr unbefriedigende niedrige Ausbeute liefert. Das vorliegende Verfahren ist dagegen breit anwendbar und zeichnet sich durch deutlich höhere Ausbeuten aus.The compounds of formula I are partly from DE-OS 27 17 440 known as total herbicides. In the same place is a method for the preparation of phosphinothricin carbanilide given, but only a very unsatisfactory one provides low yield. The present procedure is broadly applicable and is characterized by clear higher yields.
Unter "Aryl" sind allgemein Phenyl- oder Naphthylreste zu
verstehen. Als "Heteroaryl" kommen in Frage:
Pyrrolyl, Pyrrolidinyl, Thienyl, Oxazolyl, Isoxazolyl, Imidazolyl,
Pyrazolyl, Pyrazolinyl, Thiazolyl, Thiazolinyl,
Isothiazolyl, 1.3.4-Thiadiazolyl, 1.3.5- und 1.2.4-Triazinyl,
Benzthiazolyl, Benzoxazolyl, Benzimidazolyl, Pyridyl,
Pyrimidyl, Piperidinyl, Chinolyl, Isochinolyl,
Chinoxalyl oder Chinazolyl."Aryl" generally means phenyl or naphthyl radicals. The following are considered as "heteroaryl":
Pyrrolyl, pyrrolidinyl, thienyl, oxazolyl, isoxazolyl, imidazolyl, pyrazolyl, pyrazolinyl, thiazolyl, thiazolinyl, isothiazolyl, 1.3.4-thiadiazolyl, 1.3.5- and 1.2.4-triazinyl, benzothiazolyl, benzoxazolyl, benzimidazolidyl, pyrid , Quinolyl, isoquinolyl, quinoxalyl or quinazolyl.
R1 und R2 können zusammen mit dem N-Atom z. B. einen Aziridin-, Pyrrolidin-, Piperidin-, N-Methyl- oder -Ethylpiperazin-, Morpholin-, 3,5-Dimethylmorpholin-, Hexamethylenimin- oder Heptamethyleniminring bilden.R 1 and R 2 together with the N atom z. B. form an aziridine, pyrrolidine, piperidine, N-methyl or ethylpiperazine, morpholine, 3,5-dimethylmorpholine, hexamethyleneimine or heptamethyleneimine ring.
Die Verbindungen II können nach literaturbekannten Methoden (Houben-Weyl 15/2, S. 149 ff) aus Phosphinothricin (Helv. chim. Acta 55, 224-239 (1972)) hergestellt werden. Zur Maskierung der Aminogruppe eignet sich z. B. die Benzyloxycarbonyl (Cbo, Z)-, tert.-Butyloxycarbonyl (BOC)-, Phthaloyl (PHT)- oder die Trifluoracetyl (TFA)-Gruppe. Eine Maskierung der Phosphinsäuregruppe ist nicht erforderlich, obwohl diese an sich durchaus zu Reaktionen mit der Aminkomponente oder dem Kondensationsmittel befähigt wäre. Überraschenderweise bildet sich nämlich aus II unter Einwirkung von Carbodiimid oder Carbonsäureanhydrid ein cyclisches Anhydrid der Formel das die Phosphinsäuregruppe vor dem weiteren Angriff des Amins bzw. des Kondensationsmittels schützt und für den glatten Verlauf der Reaktion und die hohen Ausbeuten von kritischer Bedeutung ist. Kondensationsmittel, die die Bildung dieses cyclischen Anhydrids bewirken, sind Carbodiimide (wie Dicyclohexyl-carbodiimid) und Anhydride niederer aliphatischer Carbonsäuren wie Acetanhydrid.The compounds II can be prepared from phosphinothricin (Helv. Chim. Acta 55, 224-239 (1972)) by methods known from the literature (Houben-Weyl 15/2, p. 149 ff). For masking the amino group, z. B. the benzyloxycarbonyl (Cbo, Z) -, tert-butyloxycarbonyl (BOC) -, phthaloyl (PHT) - or the trifluoroacetyl (TFA) group. It is not necessary to mask the phosphinic acid group, although this would in itself be capable of reactions with the amine component or the condensing agent. Surprisingly, II forms a cyclic anhydride of the formula under the action of carbodiimide or carboxylic acid anhydride which protects the phosphinic acid group from further attack by the amine or the condensing agent and is of critical importance for the smooth course of the reaction and the high yields. Condensing agents that cause the formation of this cyclic anhydride are carbodiimides (such as dicyclohexyl carbodiimide) and anhydrides of lower aliphatic carboxylic acids such as acetic anhydride.
Durch Reaktion einer Aminkomponente der Formel III mit dem Anhydrid IV erfolgt Ringöffnung unter Ausbildung eines N-geschützten Phosphinothricinamids. Die Reaktionsfolge kann ohne oder mit Isolierung des Intermediats IV durchgeführt werden.By reaction of an amine component of formula III with the Anhydride IV takes place with the formation of a ring N-protected phosphinothricinamids. The reaction sequence can be carried out without or with isolation of the intermediate IV will.
(a) Bei Verwendung eines Carbodiimids wird die Kondensation der Komponenten II und III (unter intermediärer Bildung von IV) zweckmäßig in einer Eintopfreaktion durchgeführt. Man arbeitet zweckmäßigerweise in einem inerten Lösungsmittel wie CH2Cl2, Dioxan, Tetrahydrofuran, Essigsäureethylester, Dimethoxyethan, Acetonitril oder Dimethylformamid bei Temperaturen zwischen -20°C und 60°C, vorzugsweise zwischen -10°C und 50°C. Als Kondensationsmittel kommen neben Dicyclohexylcarbodiimid auch andere Dialkylcarbodiimide in Frage.(a) When using a carbodiimide, the condensation of components II and III (with the intermediate formation of IV) is advantageously carried out in a one-pot reaction. It is convenient to work in an inert solvent such as CH 2 Cl 2 , dioxane, tetrahydrofuran, ethyl acetate, dimethoxyethane, acetonitrile or dimethylformamide at temperatures between -20 ° C and 60 ° C, preferably between -10 ° C and 50 ° C. In addition to dicyclohexylcarbodiimide, other dialkylcarbodiimides are also suitable as condensing agents.
Die Aminokomponente III kann in freier Form oder als Ammoniumsalz einer anorganischen Säure, beispielsweise als Hydrochlorid, in die Reaktion eingebracht werden. In letzterem Falle muß sie durch Zusatz einer äquivalenten Menge einer tertiären organischen Base wie z. B. Triethylamin, N-Ethylmorpholin, Pyridin in die freie Form übergeführt werden. Falls die Aminkomponente weitere reaktionsfähige Gruppen enthält (wie z. B. OH, SH, COOH, NH2 oder NH-Alkyl), so müssen diese gleichfalls vorher durch Schutzgruppen inaktiviert werden. Derartige Schutzgruppen sind dem Fachmann wohlbekannt. Lediglich als Beispiele seien genannt:The amino component III can be introduced into the reaction in free form or as the ammonium salt of an inorganic acid, for example as the hydrochloride. In the latter case, it must be added by adding an equivalent amount of a tertiary organic base such. B. triethylamine, N-ethylmorpholine, pyridine can be converted into the free form. If the amine component contains other reactive groups (such as OH, SH, COOH, NH 2 or NH-alkyl), these must also be inactivated beforehand by protective groups. Such protecting groups are well known to those skilled in the art. The following are only examples:
Für die OH-Funktion: Tetrahydropyranyl (THP) oder Methoxyethoxymethyl
(MEM) (Lit.: T. W. Greene, Protective Groups
in Organic Chemistry, Verlag John Wiley & Sons, New York
1981, S. 10).
Für die SH-Funktion: Benzyl (Lit.: ibid. S. 193
Für die COOH-Funktion: Niederalkylester (Lit.: ibid. S. 152)
Für die NH2- und NHR-Funktion: vgl. oben (Lit.: ibid. S. 218)For the OH function: tetrahydropyranyl (THP) or methoxyethoxymethyl (MEM) (Lit .: TW Greene, Protective Groups in Organic Chemistry, Verlag John Wiley & Sons, New York 1981, p. 10).
For the SH function: Benzyl (Lit .: ibid. P. 193
For the COOH function: lower alkyl esters (Lit .: ibid. P. 152)
For the NH 2 and NHR function: cf. above (Lit .: ibid. p. 218)
Zur Bildung des Zwischenprodukts IV sind etwa 1-1,2 Mol Carbodiimid pro Mol II erforderlich. Man verwendet das Amin III zweckmäßig in stöchiometrischer Menge oder im Überschuß oder führt die Umsetzung in Gegenwart einer tertiären organischen Base, wie Triethylamin, N-Ethylmorpholin oder Pyridin durch.About 1-1.2 moles are required to form intermediate IV Carbodiimide required per mole of II. You use that Amine III expedient in a stoichiometric amount or in Excess or leads the reaction in the presence of a tertiary organic base such as triethylamine, N-ethylmorpholine or pyridine.
(b) Bei Verwendung eines Anhydrids (z. B. Acetanhydrid) ist es zweckmäßig, das Zwischenprodukt IV zu isolieren und es anschließend mit einem Amin der Formel III umzusetzen. Zur Bildung von IV verwendet man ca. 2-20 Moläquivalente Acetananhydrid (wobei dieses gleichzeitig als Lösungsmittel dient) und arbeitet bei Temperaturen von 0°C bis 80°C, bevorzugt 20°C-60°C. Die anschließende Umsetzung mit dem Amin erfolgt unter den gleichen Bedingungen (Temperatur, Lösungsmittel etc.) wie bei (a).(b) When using an anhydride (e.g. acetic anhydride) it is convenient to isolate intermediate IV and it then react with an amine of formula III. To Formation of IV uses about 2-20 molar equivalents Acetic anhydride (which is also a solvent serves) and works at temperatures from 0 ° C to 80 ° C, preferably 20 ° C-60 ° C. The subsequent implementation with the amine takes place under the same conditions (Temperature, solvent, etc.) as in (a).
Die Abspaltung der Schutzgruppe A geschieht in an sich bekannter Weise z. B. durch Hydrogenolyse (bei der Cbo- Gruppe), saure Hydrolyse (BOC- und TFA) oder Hydrazinolyse (PHT). Salze von I mit Säuren können in ebenfalls an sich bekannter Weise in die freien Aminoverbindungen überführt werden, z. B. durch Behandlung der Hydrohalogenide mit Propylenoxid.The protective group A is split off in itself known manner z. B. by hydrogenolysis (in the Cbo Group), acid hydrolysis (BOC and TFA) or hydrazinolysis (PHT). Salts of I with acids can also be found in converted into the free amino compounds in a known manner be, e.g. B. by treatment of the hydrohalides with propylene oxide.
Die folgenden Beispiele dienen zur Erläuterung der Erfindung: The following examples serve to illustrate the invention:
22,1 g (0,07 mol) II (A = Benzyloxycarbonyl-) und 7,5 g (0.07 mol) N-Methylanilin werden in 120 ml Tetrahydrofuran gelöst und auf 0°C abgekühlt. Bei dieser Temperatur gibt man 17,5 g (0,085 mol) Dicyclohexylcarbodiimid gelöst in 40 ml THF zu und rührt 20 h nach. Ueberschüssiges DCC zersetzt man mit 2 ml Eisessig, filtriert vom Dicyclohexylhharnstoff ab und entfernt das Lösungsmittel im Vakuum. Man nimmt in Methylenchlorid auf und zieht die org. Phase mit NaHCO3-Lösung aus. Die wässrige Phase wird mit Salzsäure auf pH 1 angesäuert und 3× mit Methylenchlorid extrahiert. Man trocknet über Natriumsulfat, entfernt das Lösungsmittel im Vakuum und erhält 22,2 g rohes 2-(N-Benzyloxycarbonylamino)-4-methyl- phosphonyl-buttersäure-N-methylphenylamid, das zur Abspaltung der Cbo-Gruppe in 120 ml Ethanol gelöst wird. Man gibt 0,5 ml Eisessig und 3 g Palladium auf Aktivkohle (5%) zu und leitet bei Raumtemperatur Wasserstoff ein bis die CO2-Entwicklung beendet ist. Abfiltrieren des Katalysators und Eindampfen liefert 13,8 g (Ausbeute über beide Stufen 73%) 2-Amino-4- methylphosphonyl-buttersäure-N-methylphenylamid vom Schmp. 135-136°C (Zers.). 22.1 g (0.07 mol) of II (A = benzyloxycarbonyl) and 7.5 g (0.07 mol) of N-methylaniline are dissolved in 120 ml of tetrahydrofuran and cooled to 0 ° C. At this temperature, 17.5 g (0.085 mol) of dicyclohexylcarbodiimide dissolved in 40 ml of THF are added and the mixture is stirred for a further 20 h. Excess DCC is decomposed with 2 ml of glacial acetic acid, the dicyclohexylurea is filtered off and the solvent is removed in vacuo. It is taken up in methylene chloride and the org. Phase out with NaHCO 3 solution. The aqueous phase is acidified to pH 1 with hydrochloric acid and extracted 3 × with methylene chloride. It is dried over sodium sulfate, the solvent is removed in vacuo and 22.2 g of crude 2- (N-benzyloxycarbonylamino) -4-methyl-phosphonyl-butyric acid-N-methylphenylamide are obtained, which is dissolved in 120 ml of ethanol to split off the Cbo group . 0.5 ml of glacial acetic acid and 3 g of palladium on activated carbon (5%) are added and hydrogen is passed in at room temperature until the evolution of CO 2 has ended. Filtering off the catalyst and evaporation gives 13.8 g (yield over both stages 73%) of 2-amino-4-methylphosphonyl-butyric acid-N-methylphenylamide, mp. 135-136 ° C. (dec.).
22,1 g (0,07 mol) II (A = Benzyloxycarbonyl-) und 12,0 g (0,07 mol) Sulfanilamid werden in 200 ml Tetrahydrofuran gelöst. Bei 0°C gibt man 17,5 g (0,085 mol) Dicyclohexylcarbodiimid in 40 ml THF zu und rührt 20 h nach. Ueberschüssiges DCC zersetzt man mit 2 ml Eisessig, filtriert vom Dicyclohexylharnstoff ab und entfernt das Lösungsmittel im Vakuum. Man nimmt in Methylenchlorid auf und zieht die org. Phase mit NaHCO3- Lösung aus. Die wässrige Phase wird mit Salzsäure auf pH 1 angesäuert und 3× mit Methylenchlorid extrahiert. Man trocknet über Natriumsulfat, entfernt das Lösungsmittel im Vakuum und erhält 29,9 g rohes 2-(N-Benzyloxycarbonylamino)- 4-methylphosphonyl-buttersäure-4- aminosulfonylphenylamid, das zur Abspaltung der Cbo- Gruppe in 600 ml Methanol gelöst wird. Man gibt 20 ml konz. HCl und 3 g Palladium auf Aktivkohle (5%) zu und leitet bei Raumtemperatur Wasserstoff ein bis die CO2-Entwicklung beendet ist. Abfiltrieren des Katalysators und Eindampfen liefert 16,8 g (Ausbeute über beide Stufen 67%) 2-Amino-4-methylphosphonyl-buttersäure- 4-aminosulfonylphenylamid-hydrochlorid vom Schmp. 243-245°C (Zers.). 22.1 g (0.07 mol) of II (A = benzyloxycarbonyl) and 12.0 g (0.07 mol) of sulfanilamide are dissolved in 200 ml of tetrahydrofuran. 17.5 g (0.085 mol) of dicyclohexylcarbodiimide in 40 ml of THF are added at 0 ° C. and the mixture is stirred for a further 20 h. Excess DCC is decomposed with 2 ml of glacial acetic acid, filtered off from the dicyclohexylurea and the solvent is removed in vacuo. It is taken up in methylene chloride and the org. Phase with NaHCO 3 solution. The aqueous phase is acidified to pH 1 with hydrochloric acid and extracted 3 × with methylene chloride. It is dried over sodium sulfate, the solvent is removed in vacuo and 29.9 g of crude 2- (N-benzyloxycarbonylamino) -4-methylphosphonyl-butyric acid-4-aminosulfonylphenylamide are obtained, which is dissolved in 600 ml of methanol to split off the Cbo group. 20 ml of conc. HCl and 3 g of palladium on activated carbon (5%) and introduces hydrogen at room temperature until the CO 2 evolution has ended. Filtration of the catalyst and evaporation gives 16.8 g (yield over both stages 67%) of 2-amino-4-methylphosphonyl-butyric acid-4-aminosulfonylphenylamide hydrochloride, mp. 243-245 ° C. (dec.).
22,1 g (0,07 mol) II (A = Benzyloxycarbonyl-) und 7,1 g (0.07 mol) Hexylamin werden in 120 ml Tetrahydrofuran gelöst. Bei 0°C gibt man 17,5 g (0.085 mol) Dicyclohexylcarbodiimid in 40 ml THF zu und rührt 20 h nach. Ueberschüssiges DCC zersetzt man mit 2 ml Eisessig, filtriert vom Dicyclohexylharnstoff ab und entfernt das Lösungsmittel im Vakuum. Man nimmt in NaHCO3-Lösung auf und wäscht mit Methylenchlorid. Die wässrige Phase wird mit Salzsäure auf pH 1 angesäuert und 3× mit Methylenchlorid extrahiert. Man trocknet über Natriumsulfat, entfernt das Lösungsmittel im Vakuum und erhält 27,0 g rohes 2-(N- Benzyloxycarbonylamino)-4-methylphosphonyl-buttersäure- hexylamid, das zur Abspaltung der Cbo-Gruppe in 100 ml Ethanol gelöst wird. Man gibt 0,5 ml Eisessig und 3 g Palladium auf Aktivkohle (5%) zu und leitet bei Raumtemperatur Wasserstoff ein bis die CO2-Entwicklung beendet ist. Das Produkt wird zusammen mit dem Katalysator abfiltriert. Man nimmt in 1 N HCl auf, filtriert den Katalysator ab und engt im Vakuum ein. Es hinterbleiben 14,0 g (Ausbeute über beide Stufen 67%) 2-Amino-4-methylphosphonyl-buttersäurehexylamid-hydrochlorid vom Schmp. 104-106°C. 22.1 g (0.07 mol) of II (A = benzyloxycarbonyl) and 7.1 g (0.07 mol) of hexylamine are dissolved in 120 ml of tetrahydrofuran. 17.5 g (0.085 mol) of dicyclohexylcarbodiimide in 40 ml of THF are added at 0 ° C. and the mixture is stirred for a further 20 h. Excess DCC is decomposed with 2 ml of glacial acetic acid, the dicyclohexylurea is filtered off and the solvent is removed in vacuo. It is taken up in NaHCO 3 solution and washed with methylene chloride. The aqueous phase is acidified to pH 1 with hydrochloric acid and extracted 3 × with methylene chloride. It is dried over sodium sulfate, the solvent is removed in vacuo and 27.0 g of crude 2- (N-benzyloxycarbonylamino) -4-methylphosphonyl-butyric acid hexylamide are obtained, which is dissolved in 100 ml of ethanol to split off the Cbo group. 0.5 ml of glacial acetic acid and 3 g of palladium on activated carbon (5%) are added and hydrogen is passed in at room temperature until the evolution of CO 2 has ended. The product is filtered off together with the catalyst. It is taken up in 1N HCl, the catalyst is filtered off and the mixture is concentrated in vacuo. It leaves 14.0 g (yield over both stages 67%) of 2-amino-4-methylphosphonyl-butyric acid hexylamide hydrochloride, mp. 104-106 ° C.
5,1 g (0,016 mol) II (A = Benzyloxycarbonyl-) werden in 25 ml Acetanhydrid suspendiert. Nach dreistündigem Rühren bei 40°C erhält man eine klare Lösung. Man dampft ein, entfernt leichtflüchtige Bestandteile im Hochvakuum und löst den Rückstand - das cyclische Anhydrid der Formel IV - in 100 ml Methylenchlorid. Bei 0°C tropft man 3,0 g (0,032 mol) Anilin in 30 ml Methylenchlorid zu und rührt 1 h bei Raumtemperatur nach. Danach wird die Lösung nacheinander mit 100 ml 1 N HCl und 100 ml Wasser gewaschen, über Natriumsulfat getrocknet und im Vakuum eingedampft. Es hinterbleiben 5,0 g rohes 2-(N-Benzyloxycarbonyl-4-methyl- phosphonyl-buttersäure-phenylamid, das zur Abspaltung der Cbo-Gruppe in 100 ml Ethanol gelöst wird. Man gibt 1 g Palladium auf Aktivkohlle (5%) zu und leitet Wasserstoff ein bis die CO2-Entwicklung beendet ist. Das Produkt wird zusammen mit dem Katalysator abfiltriert. Man nimmt in 1 N HCl auf, filtriert den Katalysator ab und engt im Vakuum ein. Es hinterbleiben 3,6 g (Ausbeute über alle Stufen 77%) 2-Amino-4-methylphosphonyl- buttersäurephenylamid-hydrochlorid vom Schmp. 140-143°C (Zers.). 5.1 g (0.016 mol) of II (A = benzyloxycarbonyl) are suspended in 25 ml of acetic anhydride. After stirring for three hours at 40 ° C., a clear solution is obtained. It is evaporated, volatile constituents are removed under high vacuum and the residue - the cyclic anhydride of the formula IV - is dissolved in 100 ml of methylene chloride. 3.0 g (0.032 mol) of aniline in 30 ml of methylene chloride are added dropwise at 0 ° C. and the mixture is stirred at room temperature for 1 h. The solution is then washed successively with 100 ml of 1N HCl and 100 ml of water, dried over sodium sulfate and evaporated in vacuo. 5.0 g of crude 2- (N-benzyloxycarbonyl-4-methyl-phosphonyl-butyric acid-phenylamide remain, which is dissolved in 100 ml of ethanol to split off the Cbo group. 1 g of palladium on activated carbon (5%) is added and introduces hydrogen until the evolution of CO 2 is complete. The product is filtered off together with the catalyst. It is taken up in 1N HCl, the catalyst is filtered off and concentrated in vacuo. 3.6 g (yield over all Steps 77%) 2-amino-4-methylphosphonylbutyric acidphenylamide hydrochloride of mp. 140-143 ° C (dec.).
Die nachfolgenden in Tabelle 1 aufgeführten Verbindungen der allgemeinen Formel I können in analoger Weise erhalten werden.The following compounds listed in Table 1 of the general formula I can be obtained in an analogous manner will.
Claims (2)
R1 und R2 unabhängig voneinander Wasserstoff, (C1-C12)- Alkyl, (C3-C8)-Alkenyl, (C3-C8)-Alkinyl, (C3-C8)-Cycloalkyl, Aryl, Heteroaryl mit 1 oder 2 N-, O- oder S- Atomen, Aryl-(C1-C2)-alkyl, Arylamino, wobei die genannten Gruppen ihrerseits durch ein oder mehrere Halogenatome, NH2, NH-(C1-C4)-Alkyl, OH, SH, NO2, CF3, (C1-C4)-Alkoxy, Aryloxy, (C1-C4)-Alkylthio, (C1-C4)- Alkoxycarbonyl, COOH, CONH2, CN, ((C1-C4)Alkylamino), Di-(C1-C4)-alkylamino -oder Sulfamoyl substituiert sein können, oder
R1 und R2 gemeinsam eine gegebenenfalls substituierte (C2-C7)-Alkylenkette, die durch ein oder mehrere Heteroatome unterbrochen sein kann,
bedeuten, sowie von deren Salzen, das dadurch gekennzeichnet ist, daß man Phosphinothricinderivate der Formel worin
A eine übliche Aminoschutzgruppe bedeutet, mit einem Kondensationsmittel aus der Reihe der Carbodiimide oder Carbonsäureanhydride und einem Amin der Formel umsetzt und die Schutzgruppen anschließend abspaltet.1. Process for the preparation of carboxamides of the general formula wherein
R 1 and R 2 independently of one another are hydrogen, (C 1 -C 12 ) alkyl, (C 3 -C 8 ) alkenyl, (C 3 -C 8 ) alkynyl, (C 3 -C 8 ) cycloalkyl, aryl , Heteroaryl with 1 or 2 N, O or S atoms, aryl (C 1 -C 2 ) alkyl, arylamino, where the groups mentioned in turn are formed by one or more halogen atoms, NH 2 , NH- (C 1 - C 4 ) alkyl, OH, SH, NO 2 , CF 3 , (C 1 -C 4 ) alkoxy, aryloxy, (C 1 -C 4 ) alkylthio, (C 1 -C 4 ) alkoxycarbonyl, COOH, CONH 2 , CN, ((C 1 -C 4 ) alkylamino), di (C 1 -C 4 ) alkylamino or sulfamoyl may be substituted, or
R 1 and R 2 together form an optionally substituted (C 2 -C 7 ) alkylene chain which can be interrupted by one or more heteroatoms,
mean, and of their salts, which is characterized in that phosphinothricine derivatives of the formula wherein
A represents a common amino protecting group, with a condensing agent from the series of carbodiimides or carboxylic anhydrides and an amine of the formula implemented and the protective groups then split off.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19853544373 DE3544373A1 (en) | 1985-12-14 | 1985-12-14 | Process for the preparation of phosphinothricin-carboxamides |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19853544373 DE3544373A1 (en) | 1985-12-14 | 1985-12-14 | Process for the preparation of phosphinothricin-carboxamides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE3544373A1 true DE3544373A1 (en) | 1987-06-19 |
Family
ID=6288516
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19853544373 Withdrawn DE3544373A1 (en) | 1985-12-14 | 1985-12-14 | Process for the preparation of phosphinothricin-carboxamides |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE3544373A1 (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4922013A (en) * | 1988-05-20 | 1990-05-01 | Hoechst Aktiengesellschaft | Process for the racemization of optically active D-2-N-phenacetylamino-4-methylphosphinobutyric acid |
| EP1546110A4 (en) * | 2002-07-30 | 2008-03-26 | Univ Virginia | ACTIVE COMPOUNDS IN THE SIGNALING OF SPHINGOSINE 1-PHOSPHATE |
| US7754703B2 (en) | 2005-02-14 | 2010-07-13 | University Of Virginia Patent Foundation | Cycloalkane-containing sphingosine 1-phosphate agonists |
| US7786173B2 (en) | 2006-11-21 | 2010-08-31 | University Of Virginia Patent Foundation | Tetralin analogs having sphingosine 1-phosphate agonist activity |
| US7915315B2 (en) | 2006-11-21 | 2011-03-29 | University Of Virginia Patent Foundation | Benzocycloheptyl analogs having sphingosine 1-phosphate receptor activity |
| US7964649B2 (en) | 2006-11-21 | 2011-06-21 | University Of Virginia Patent Foundation | Hydrindane analogs having sphingosine 1-phosphate receptor agonist activity |
| US8008286B2 (en) | 2006-01-27 | 2011-08-30 | University Of Virginia Patent Foundation | Method for treatment of neuropathic pain |
| US8173710B2 (en) | 2006-02-09 | 2012-05-08 | University Of Virginia Patent Foundation | Bicyclic sphingosine 1-phosphate analogs |
-
1985
- 1985-12-14 DE DE19853544373 patent/DE3544373A1/en not_active Withdrawn
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4922013A (en) * | 1988-05-20 | 1990-05-01 | Hoechst Aktiengesellschaft | Process for the racemization of optically active D-2-N-phenacetylamino-4-methylphosphinobutyric acid |
| EP1546110A4 (en) * | 2002-07-30 | 2008-03-26 | Univ Virginia | ACTIVE COMPOUNDS IN THE SIGNALING OF SPHINGOSINE 1-PHOSPHATE |
| US7560477B2 (en) | 2002-07-30 | 2009-07-14 | University Of Virginia Patent Foundation | Compounds active in sphingosine 1-phosphate signaling |
| US7754703B2 (en) | 2005-02-14 | 2010-07-13 | University Of Virginia Patent Foundation | Cycloalkane-containing sphingosine 1-phosphate agonists |
| US8329676B2 (en) | 2005-02-14 | 2012-12-11 | University Of Virginia Patent Foundation | Cycloalkane-containing sphingosine 1-phosphate agonists |
| US8008286B2 (en) | 2006-01-27 | 2011-08-30 | University Of Virginia Patent Foundation | Method for treatment of neuropathic pain |
| US8173710B2 (en) | 2006-02-09 | 2012-05-08 | University Of Virginia Patent Foundation | Bicyclic sphingosine 1-phosphate analogs |
| US7786173B2 (en) | 2006-11-21 | 2010-08-31 | University Of Virginia Patent Foundation | Tetralin analogs having sphingosine 1-phosphate agonist activity |
| US7915315B2 (en) | 2006-11-21 | 2011-03-29 | University Of Virginia Patent Foundation | Benzocycloheptyl analogs having sphingosine 1-phosphate receptor activity |
| US7964649B2 (en) | 2006-11-21 | 2011-06-21 | University Of Virginia Patent Foundation | Hydrindane analogs having sphingosine 1-phosphate receptor agonist activity |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE19519245C2 (en) | Novel arylglycine amide derivatives, processes for their preparation and pharmaceutical compositions containing them | |
| EP0824530A1 (en) | Aryl glycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds | |
| DE2901843A1 (en) | METHOD FOR PRODUCING CARBONIC ACID AMIDES AND PEPTIDES | |
| DE3544373A1 (en) | Process for the preparation of phosphinothricin-carboxamides | |
| DE2414751A1 (en) | NEW 4H PYRIDO SQUARE CLAMP ON 1.2A SQUARE CLAMP FOR PYRIMIDINE DERIVATIVES AND METHOD OF MANUFACTURING THE SAME | |
| DE1934037A1 (en) | Basically substituted derivatives of 2,4- (1H, 3H) -quinazolinedione | |
| DE3438694A1 (en) | NEW AMIDOALKYLMELAMINE AND AMINOALKYLMELAMINE AND METHOD FOR THE PRODUCTION THEREOF | |
| DE2114884A1 (en) | Basically substituted derivatives of 1 (2H) -phthalazinone | |
| DE2256979C3 (en) | Process for the preparation of benzenesulfonylureas | |
| DE2747122A1 (en) | DERIVATIVES OF 6- (M-AMINOPHENYL) -2, 3,5,6-TETRAHYDROIMIDAZO SQUARE CLAMP ON 2.1-B SQUARE CLAMP FOR -THIAZOLE, PROCESS FOR THEIR PRODUCTION AND THEIR USE | |
| DE1158082B (en) | Process for the preparation of alkylenediamine derivatives and their salts | |
| DE1670143C3 (en) | ||
| DE2064061B2 (en) | ||
| DE1926076A1 (en) | Basically substituted derivatives of 1,2,3-benzotriazin-4 (3H) -one | |
| DE2114573C3 (en) | 4-aminomethylbicyclo [2,2,2] -octanecarboxylic acid phenyl ester and their salts | |
| CH616914A5 (en) | ||
| DE968561C (en) | Process for the preparation of monoaminoacylanilides substituted on the amino nitrogen | |
| DE2709720A1 (en) | Hypotensive 1-oxy-2-arylamino-2-imidazoline derivs. - prepd. by reacting N-oxy-ethylene:di:amine cpds. with N-phenyl-isocyanide di:chloride cpds. | |
| DE944854C (en) | Process for the preparation of halogenated 8-oxyquinoline compounds | |
| DE2233862B2 (en) | PROCESS FOR THE PRODUCTION OF DIMETHYLMALEIC ACID ANHYDRIDE | |
| DE2728870C2 (en) | Process for the production of D-penicillamine and its salts | |
| AT148475B (en) | Process for the preparation of quaternary amino compounds. | |
| DE1670698C3 (en) | Sulfomamide derivatives and processes for their preparation | |
| DE2659053C3 (en) | N-substituted l ^ -trimethyl-S-carboxamido-cyclopentanecarboxylic acids (l) (a-campheramic acids), the physiologically acceptable salts, processes for their preparation and pharmaceuticals containing them | |
| DE2419535C3 (en) | 6-aminonicotinic acid amides, processes for their preparation and pharmaceuticals containing these compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8130 | Withdrawal |